SHL Telemedicine Ltd. (SHLT)
SHL Telemedicine Statistics
Share Statistics
SHL Telemedicine has 16.39M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 16.39M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 8.87M |
| Failed to Deliver (FTD) Shares | 2.2K |
| FTD / Avg. Volume | 43.18% |
Short Selling Information
The latest short interest is 6.87K, so undefined% of the outstanding shares have been sold short.
| Short Interest | 6.87K |
| Short % of Shares Out | undefined% |
| Short % of Float | 0.04% |
| Short Ratio (days to cover) | 0.57 |
Valuation Ratios
The PE ratio is -18.4 and the forward PE ratio is -10.75. SHL Telemedicine's PEG ratio is 0.
| PE Ratio | -18.4 |
| Forward PE | -10.75 |
| PS Ratio | 2.27 |
| Forward PS | 0.4 |
| PB Ratio | 1.77 |
| P/FCF Ratio | -18.63 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for SHL Telemedicine.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.3, with a Debt / Equity ratio of 0.27.
| Current Ratio | 2.3 |
| Quick Ratio | 2.1 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 6.05 |
| Debt / FCF | -2.85 |
| Interest Coverage | -5.77 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $97.9K |
| Profits Per Employee | $-12.1K |
| Employee Count | 583 |
| Asset Turnover | 0.5 |
| Inventory Turnover | 9.2 |
Taxes
| Income Tax | 891K |
| Effective Tax Rate | -14.94% |
Stock Price Statistics
The stock price has increased by -64.66% in the last 52 weeks. The beta is 0.29, so SHL Telemedicine's price volatility has been higher than the market average.
| Beta | 0.29 |
| 52-Week Price Change | -64.66% |
| 50-Day Moving Average | 2.44 |
| 200-Day Moving Average | 3.28 |
| Relative Strength Index (RSI) | 39.62 |
| Average Volume (20 Days) | 5.09K |
Income Statement
In the last 12 months, SHL Telemedicine had revenue of 57.08M and earned -7.06M in profits. Earnings per share was -0.43.
| Revenue | 57.08M |
| Gross Profit | 25.26M |
| Operating Income | -9.01M |
| Net Income | -7.06M |
| EBITDA | 3.28M |
| EBIT | -4.67M |
| Earnings Per Share (EPS) | -0.43 |
Balance Sheet
The company has 6.69M in cash and 19.86M in debt, giving a net cash position of -13.17M.
| Cash & Cash Equivalents | 6.69M |
| Total Debt | 19.86M |
| Net Cash | -13.17M |
| Retained Earnings | -80.13M |
| Total Assets | 102.84M |
| Working Capital | 17.88M |
Cash Flow
In the last 12 months, operating cash flow was -1.5M and capital expenditures -5.48M, giving a free cash flow of -6.97M.
| Operating Cash Flow | -1.5M |
| Capital Expenditures | -5.48M |
| Free Cash Flow | -6.97M |
| FCF Per Share | -0.43 |
Margins
Gross margin is 44.26%, with operating and profit margins of -15.78% and -12.36%.
| Gross Margin | 44.26% |
| Operating Margin | -15.78% |
| Pretax Margin | -10.45% |
| Profit Margin | -12.36% |
| EBITDA Margin | 5.75% |
| EBIT Margin | -15.78% |
| FCF Margin | -12.21% |
Dividends & Yields
SHLT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for SHLT is $11, which is 436.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $11 |
| Price Target Difference | 436.6% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | -0.01 |
| Piotroski F-Score | 4 |